ARGX:NASDAQ
argenx SE - ADR
919,21 US$
arrow_downward
-1,79%(-16,79) 1D
919,21 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 2 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
926,86 US$
High
928,96 US$
Low
912,96 US$
Mkt. cap
58,57 მლრდ.
Avg. vol.
255,29 ათ.
Volume
333,88 ათ.
P/E ratio
34,92
52-wk high
1 072,75 US$
52-wk low
661,85 US$
EPS
26,32 US$
Beta
0,45
Shares outstanding
62,56 მლნ.
No. of employees
2 ათ.
Open
926,86 US$
High
928,96 US$
Low
912,96 US$
Mkt. cap
58,57 მლრდ.
Avg. vol.
255,29 ათ.
Volume
333,88 ათ.
P/E ratio
34,92
52-wk high
1 072,75 US$
52-wk low
661,85 US$
EPS
26,32 US$
Beta
0,45
Shares outstanding
62,56 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
AD HOC NEWS
·
18 საათის წინ
Argenx stock after-hours at EUR 815.70: minus 2.59 percent versus prior close
AD HOC NEWS
·
1 დღის წინ
Goldman Sachs raises target for Argenx stock from EUR 973 to EUR 982
AD HOC NEWS
·
2 დღის წინ
argenx stock falls 2.06 percent as VYVGART data arrive
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR